ODT Insider Trading Activity and SEC Form 4 Filings
ODT insider trading summary
No open-market insider purchases or sales of Odonate Therapeutics, Inc. (ODT) have been reported on SEC Form 4 in the past 12 months.
Latest ODT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 10, 2021 | EcoR1 Capital, LLC | 10% Owner | Sell | $8.3M (5,000,000 @ $1.66) |
| Dec 10, 2021 | EcoR1 Capital, LLC | 10% Owner | Sell | $847K (545,000 @ $1.55) |
| Dec 9, 2021 | EcoR1 Capital, LLC | 10% Owner | Sell | $285K (156,669 @ $1.82) |
| Dec 1, 2021 | EcoR1 Capital, LLC | 10% Owner | Sell | $309K (185,941 @ $1.66) |
| Dec 1, 2021 | EcoR1 Capital, LLC | 10% Owner | Buy | $309K (185,941 @ $1.66) |
| Nov 24, 2021 | Boxer Capital, LLC | 10% Owner | Sell | $314K (200,000 @ $1.57) |
| Nov 24, 2021 | Joseph Lewis | 10% Owner | Sell | $314K (200,000 @ $1.57) |
| Nov 24, 2021 | Boxer Asset Management Inc. | 10% Owner | Sell | $314K (200,000 @ $1.57) |
| Nov 22, 2021 | Boxer Capital, LLC | 10% Owner | Sell | $310K (200,000 @ $1.55) |
| Nov 22, 2021 | Boxer Asset Management Inc. | 10% Owner | Sell | $310K (200,000 @ $1.55) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.